LabCorp
$228.269876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$228.26
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.64 (-0.28%) As of 2:48 PM UTC today
Why Robinhood?
You can buy or sell LabCorp and other stocks, options, and ETFs commission-free!
About LH
Laboratory Corporation of America Holdings, also called LabCorp, is a clinical laboratory company. The firm engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the following segments: LabCorp Diagnostics and Covance Drug Development. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment provides drug development solutions to companies in the pharmaceutical and biotechnology industries. The company was founded in 1971 and is headquartered in Burlington, NC. The listed name for LH is Laboratory Corporation of America Holdings.
CEO
Adam H. Schechter
Employees
65,000
Headquarters
Burlington, North Carolina
Founded
1971
Market Cap
22.31B
Price-Earnings Ratio
26.63
Dividend Yield
—
Average Volume
764.53K
High Today
$229.83
Low Today
$227.20
Open Price
$229.72
Volume
54.89K
52 Week High
$230.77
52 Week Low
$98.02
Collections
Analyst Ratings
84%
of 19 ratings
Buy
84%
Hold
16%
Sell
0%
LH Earnings
$0.00
$2.80
$5.61
$8.41
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Available Feb 11, Pre-Market